UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis

PloS one, 2018-12, Vol.13 (12), p.e0208534-e0208534

2018

Volltextzugriff (PDF)

CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis

Arthritis research & therapy, 2015-11, Vol.17 (1), p.344-344, Article 344

2015

Volltextzugriff (PDF)

TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol

Trials, 2020-10, Vol.21 (1), p.862-862, Article 862

2020

Volltextzugriff (PDF)

Effect of Methotrexate Use and Erythrocyte Methotrexate Polyglutamate on Glycosylated Hemoglobin in Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2014-08, Vol.66 (8), p.2026-2036

2014

Volltextzugriff (PDF)

Response to: ‘Tapering antirheumatic drugs in a resource-poor setting: real-world evidence’ by Haroon et al

Annals of the rheumatic diseases, 2022-10, Vol.81 (10), p.e209-e209

2022

Volltextzugriff (PDF)

Methotrexate Polyglutamates Exposure – Response Modeling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate

Clinical pharmacology and therapeutics, 2023-10, Vol.114 (4), p.893-903

2023

Volltextzugriff (PDF)

Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis

Rheumatology, 2023-07, Vol.62 (7), p.2402-2409

2023

Volltextzugriff (PDF)

Realising early recognition of arthritis in times of increased telemedicine: the value of patient-reported swollen joints

Annals of the rheumatic diseases, 2021-05, Vol.80 (5), p.668-669

2021

Volltextzugriff (PDF)

Factors that influence biological survival in rheumatoid arthritis: results of a real-world academic cohort from the Netherlands

Clinical rheumatology, 2021-06, Vol.40 (6), p.2177-2183

2021

Volltextzugriff (PDF)

Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors

Annals of the rheumatic diseases, 2018-09, Vol.77 (9), p.1261-1267

2018

Volltextzugriff (PDF)

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2023-04, Vol.82 (4), p.468-475

2023

Volltextzugriff (PDF)

Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al

Annals of the rheumatic diseases, 2020-07, Vol.79 (7), p.e80-e80

2020

Volltextzugriff (PDF)

Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands

Patient preference and adherence, 2023-01, Vol.17, p.167-174

2023

Volltextzugriff (PDF)

Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis

Annals of the rheumatic diseases, 2019-01, Vol.78 (1), p.142-144

2019

Volltextzugriff (PDF)

Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis?

Rheumatic & musculoskeletal diseases open, 2024-07, Vol.10 (3), p.e004258

2024

Volltextzugriff (PDF)

When does obesity exert its effect in conferring risk of developing RA: a large study in cohorts of symptomatic persons at risk

Rheumatic & musculoskeletal diseases open, 2024-01, Vol.10 (1), p.e003785

2024

Volltextzugriff (PDF)

Patient-reported outcomes and radiographic progression in patients with rheumatoid arthritis in sustained remission versus low disease activity

Rheumatic & musculoskeletal diseases open, 2024-02, Vol.10 (1), p.e003860

2024

Volltextzugriff (PDF)

Window of opportunity in psoriatic arthritis: the earlier the better?

Rheumatic & musculoskeletal diseases open, 2024-02, Vol.10 (1), p.e004062

2024

Volltextzugriff (PDF)

Scleritis in rheumatoid arthritis: Before and during biologic era

Frontiers in ophthalmology, 2023, Vol.3, p.1106419

2023

Volltextzugriff (PDF)

Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry

JMIR research protocols, 2023-03, Vol.12, p.e43230-e43230

2023

Volltextzugriff (PDF)

The course of cytokine and chemokine gene expression in clinically suspect arthralgia patients during progression to inflammatory arthritis

Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.563-570

2024

Volltextzugriff (PDF)

Clinically suspect arthralgia patients with a low educational attainment have an increased risk of developing inflammatory arthritis

Rheumatology (Oxford, England), 2023-05, Vol.62 (5), p.1944-1949

2023

Volltextzugriff (PDF)

Subclinical synovitis in arthralgia: how often does it result in clinical arthritis? Reflecting on starting points for disease-modifying anti-rheumatic drug treatment

Rheumatology (Oxford, England), 2021-08, Vol.60 (8), p.3872-3878

2021

Volltextzugriff (PDF)

Work participation is reduced during the development of RA, months before clinical arthritis manifests

Rheumatology (Oxford, England), 2022-05, Vol.61 (6), p.2583-2589

2022

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(96)
Tagungsberichte
(2)

Sprache

Englisch
(98)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(65)
Rheumatology
(39)
Humans
(37)
Rheumatoid Arthritis
(29)
Male
(24)
Female
(23)
Middle Aged
(19)
Patients
(18)
Arthritis, Rheumatoid - Drug Therapy
(11)
Aged
(10)
Antirheumatic Agents - Therapeutic Use
(10)
Methotrexate
(10)
Adult
(9)
Arthritis
(9)
Biological And Medical Sciences
(9)
Cohort Studies
(9)
Medical Sciences
(9)
Remission
(9)
Inflammation
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Rheumatology
(17)
Annals Of The Rheumatic Diseases
(10)
Rheumatic & Musculoskeletal Diseases Open
(6)
Rmd Open
(4)
Bmc Gastroenterology
(3)
Clinical Endocrinology
(3)
Elife
(3)
Neuron
(3)
Arthritis Research & Therapy
(2)
Chemical Communications
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis

CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis

TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol

Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial

Effect of Methotrexate Use and Erythrocyte Methotrexate Polyglutamate on Glycosylated Hemoglobin in Rheumatoid Arthritis

Response to: ‘Tapering antirheumatic drugs in a resource-poor setting: real-world evidence’ by Haroon et al

Methotrexate Polyglutamates Exposure – Response Modeling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate

Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis

Realising early recognition of arthritis in times of increased telemedicine: the value of patient-reported swollen joints

Factors that influence biological survival in rheumatoid arthritis: results of a real-world academic cohort from the Netherlands

Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis

Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al

Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands

Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis

Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis?

When does obesity exert its effect in conferring risk of developing RA: a large study in cohorts of symptomatic persons at risk

Patient-reported outcomes and radiographic progression in patients with rheumatoid arthritis in sustained remission versus low disease activity

Window of opportunity in psoriatic arthritis: the earlier the better?

Scleritis in rheumatoid arthritis: Before and during biologic era

Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry

The course of cytokine and chemokine gene expression in clinically suspect arthralgia patients during progression to inflammatory arthritis

Clinically suspect arthralgia patients with a low educational attainment have an increased risk of developing inflammatory arthritis

Subclinical synovitis in arthralgia: how often does it result in clinical arthritis? Reflecting on starting points for disease-modifying anti-rheumatic drug treatment

Work participation is reduced during the development of RA, months before clinical arthritis manifests

Suchergebnisse filtern